Cargando…
Safety of Real-life Usage of Advanced Hybrid Closed-Loop System MiniMed 780G in Children With Type 1 Diabetes Younger Than 7 Years Old
Autores principales: | Tornese, Gianluca, Carletti, Claudia, Lanzetta, Maria Andrea, Tamaro, Gianluca, Barbi, Egidio, Faleschini, Elena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10234753/ https://www.ncbi.nlm.nih.gov/pubmed/37068287 http://dx.doi.org/10.2337/dc22-2046 |
Ejemplares similares
-
Six-Month Effectiveness of Advanced vs. Standard Hybrid Closed-Loop System in Children and Adolescents With Type 1 Diabetes Mellitus
por: Tornese, Gianluca, et al.
Publicado: (2021) -
Carbohydrate Tolerance Threshold for Unannounced Snacks in Children and Adolescents With Type 1 Diabetes Using an Advanced Hybrid Closed-Loop System
por: Tornese, Gianluca, et al.
Publicado: (2022) -
Real-World User and Clinician Perspective and Experience with MiniMed™ 780G Advanced Hybrid Closed Loop System
por: Kesavadev, Jothydev, et al.
Publicado: (2023) -
Glycemic Outcomes During Early Use of the MiniMed™ 780G Advanced Hybrid Closed-Loop System with Guardian™ 4 Sensor
por: Cordero, Toni L., et al.
Publicado: (2023) -
Pattern and Features of Pediatric Endocrinology Referrals: A Retrospective Study in a Single Tertiary Center in Italy
por: Bellotto, Eleonora, et al.
Publicado: (2020)